Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
- PMID: 36935649
- PMCID: PMC10121279
- DOI: 10.3350/cmh.2023.0054
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Erratum in
-
Erratum to 'Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?' [Clin Mol Hepatol 2023;29:367-370].Clin Mol Hepatol. 2023 Jul;29(3):828-829. doi: 10.3350/cmh.2023.0054e. Epub 2023 Apr 13. Clin Mol Hepatol. 2023. PMID: 37344939 Free PMC article. No abstract available.
Keywords: Biopsy; Fibrosis; Hepatitis B, chronic.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment in
-
Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".Clin Mol Hepatol. 2023 Jul;29(3):812. doi: 10.3350/cmh.2023.0132. Epub 2023 May 8. Clin Mol Hepatol. 2023. PMID: 37157773 Free PMC article. No abstract available.
Comment on
-
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5. Clin Mol Hepatol. 2023. PMID: 36603573 Free PMC article.
References
-
- Hong YM, Yoon KT. [Definition and management of the immune tolerance phase in chronic hepatitis B] Korean J Gastroenterol. 2022;79:156–160. Korean. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
